Key facts
- This page summarizes Jong Joseph Kim's Form 4 filing for INOVIO PHARMACEUTICALS, INC. (INO).
- 5 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 01 Mar 2022, 17:38.
Jong Joseph Kim - 26 Feb 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- INO
- Reported as of
- 26 Feb 2022
- Net transaction value
- -$64,545
- SEC form
- 4
- Accepted by SEC
- 01 Mar 2022, 17:38:58 UTC
- Next SEC filing
- 09 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jong Joseph Kim
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jong Joseph Kim filed Form 4 for INOVIO PHARMACEUTICALS, INC. (INO) on 01 Mar 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$64,545.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INO
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +68,767
- Change %
- +5.6%
- Price
- Shares after
- 1,297,425
- Date
- 26 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
INO
transaction
Common Stock
Tax liability
- Transaction value
- $64,545
- Shares
- -20,045
- Change %
- -1.5%
- Price
- $3.22*
- Shares after
- 1,277,380
- Date
- 26 Feb 2022
- Ownership
- Direct
- Footnotes
- F2
INO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 816,527
- Date
- 26 Feb 2022
- Ownership
- By Family Limited Partnership
INO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 33,563
- Date
- 26 Feb 2022
- Ownership
- By Daughter: EK
INO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 33,775
- Date
- 26 Feb 2022
- Ownership
- By Son: JK1
INO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,975
- Date
- 26 Feb 2022
- Ownership
- By Spouse
INO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 33,533
- Date
- 26 Feb 2022
- Ownership
- By Son: JK2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INO
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -68,767
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 137,533
- Date
- 26 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 68,767
- Exercise price
- Footnotes
- F1
INO
transaction
Derivative
Common Stock Option
Award
- Transaction value
- $0
- Shares
- +627,700
- Change %
- Price
- $0.000000
- Shares after
- 627,700
- Date
- 26 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 627,700
- Exercise price
- $3.22
- Footnotes
- F3
INO
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +468,500
- Change %
- Price
- $0.000000
- Shares after
- 468,500
- Date
- 26 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 468,500
- Exercise price
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 206,300 restricted stock units is as follows: 68,767 shares vested on February 26, 2022; 68,767 shares will vest on February 26, 2023; 68,766 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Footnote F2
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
Footnote F3
The vesting schedule for the 627,700 options is as follows: 156,925 shares vested on February 26, 2022; 156,925 shares will vest on February 26, 2023; 156,925 shares will vest on February 26, 2024; 156,925 shares will vest on February 26, 2025.
Footnote F4
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 468,500 restricted stock units is as follows: 156,167 shares will vest on February 26, 2023; 156,167 shares will vest on February 26, 2024; 156,166 shares will vest on February 26, 2025. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.